Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
Clinical trial NCT07363642 · RECRUITING
Trial details
- NCT number
- NCT07363642
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-28
- Primary completion
- 2027-08-07
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.